Back
Supports Timeline Adherence
The Core Principle
In drug development, time is money and, more importantly, time can save lives. Understanding site capabilities, patient availability, and regulatory hurdles helps in creating a realistic and achievable timeline.
Why It's Critical
A well-planned trial avoids the common pitfalls that lead to delays, such as slow recruitment or site start-up issues. This accelerates the delivery of new therapies to patients who are waiting.
Real-World Impact
A company projects a 12-month timeline for their trial. Feasibility analysis of site start-up times and IRB review cycles shows a more realistic timeline of 18 months. The company adjusts its public forecasts and internal planning, maintaining credibility with investors and partners.